The trademark application MENOAID was filed by Hisamitsu Pharmaceutical Co., Inc., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on January 19, 2022, and it was registered by office on April 28, 2022 without any oppositions.
The application was filed in English (Italian was selected as the second language).
The Refusal with reference B 018188025 was partially rejected according to Article 7(1)(b) EUTMR with decision issued on February 18, 2021 by the EUIPO.